Explore the vast range of titles available.

Denosumab and romosozumab, a recently approved new drug, are effective and widely known molecular-targeted drugs for postmenopausal osteoporosis treatment. However, no studies have directly compared their therapeutic effects or safety in postmenopausal osteoporosis. This retrospective observational registry study compared the efficacy of 12-month denosumab or romosozumab treatment in postmenopausal osteoporosis patients. The primary outcome was the change in bone mineral density (BMD) at the lumbar spine. Secondary outcomes included BMD changes at the total hip and femoral neck, changes in bone turnover markers, and adverse events. Propensity score matching was employed to assemble patient groups with similar baseline characteristics. Sixty-nine patients each received either denosumab or romosozumab for 12 months. The mean 12-month percentage change from baseline in lumbar spine BMD was 7.2% in the denosumab group and 12.5% in the romosozumab group, indicating a significant difference between the groups. The percentage changes in BMD at both the total hip and femoral neck were also significantly higher at 12 months in the romosozumab group than in the denosumab group. In denosumab patients, bone formation and bone resorption markers were significantly decreased at 6 and 12 months from baseline. In the romosozumab group, the bone formation marker was significantly increased at 6 months and then returned to baseline, while the bone resorption marker was significantly decreased at both time points. Adverse events were few and predominantly minor in both groups, with no remarkable difference in the incidence of new vertebral fractures. Romosozumab showed a higher potential for improving BMD than denosumab in this clinical study of postmenopausal osteoporosis patient treatment.

Oxygen-containing carbon materials such as graphene oxide have been extensively studied because of their high dispersibility. However, the oxygen-containing functional groups in most carbon materials are not controlled. Uncontrollability of the synthesis is also one of factors that prevent industrialization. Carbon materials derived from phloroglucinol (PG), which show high solubility/dispersibility and controllability of functional groups, have been developed recently by our group. The high performance of carbonized PG originates from the thermally stable backbone structure of the benzene ring with hydroxy groups of PG. However, the degree of carbonization was low. In this study, five heteropoly acids (HPAs), which are thermally stable homogeneous strong acid catalysts, were used to promote carbonization of PG without losing the controllability of functional groups and the dispersibility. HPAs promoted etherification of hydroxy groups followed by C=C coupling reactions (furan cyclization) at 523 K. Furthermore, it was confirmed that particularly furan structures, which contribute to solubility/dispersibility in solvents, and thermal stability in air, could be maintained at 673 K as suggested by spectroscopies and thermogravimetric-differential thermal analysis. Among five HPAs, phosphotungstic acid worked as the excellent catalyst to promote carbonization of PG containing furan structures, exhibiting high solubility/dispersibility and high thermal stability in air. Graphic abstract

Most anti-influenza drugs currently used, such as oseltamivir and zanamivir, inhibit the enzymatic activity of neuraminidase. However, neuraminidase inhibitor-resistant viruses have already been identified from various influenza virus isolates. Here, we report the development of a class of macrocyclic peptides that bind the influenza viral envelope protein hemagglutinin, named iHA. Of 28 iHAs examined, iHA-24 and iHA-100 have inhibitory effects on the in vitro replication of a wide range of Group 1 influenza viruses. In particular, iHA-100 bifunctionally inhibits hemagglutinin-mediated adsorption and membrane fusion through binding to the stalk domain of hemagglutinin. Moreover, iHA-100 shows powerful efficacy in inhibiting the growth of highly pathogenic influenza viruses and preventing severe pneumonia at later stages of infection in mouse and non-human primate cynomolgus macaque models. This study shows the potential for developing cyclic peptides that can be produced more efficiently than antibodies and have multiple functions as next-generation, mid-sized biomolecules. Here, the authors report bi-functional, wide tropic macrocycles that bind the influenza viral envelope protein hemagglutinin and inhibit virus infection by blocking adsorption and fusion and show efficacy in preventing severe pneumonia at later stages of infection in mouse and non-human primate cynomolgus macaque models.

Background\\nOptimum timing of umbilical cord clamping has not been established in preterm infants.\\nObjectives\\nWe compared the short- and long-term effects of umbilical cord milking (UCM) versus delayed cord clamping (DCC) on infants born at less than 37 weeks of gestation.\\nSearch methods\\nA systematic review and meta-analysis was conducted according to the \"Preferred Reporting Items for Systematic Reviews and Meta-Analyses\" statement. We searched CINAHL, CENTRAL, EMBASE, MEDLINE, PubMed and ClinicalTrials.gov for relevant randomized controlled trials (RCTs).\\nSelection criteria\\nWe included individual and clustered RCTs comparing UCM to DCC for infants born before 37 weeks of gestation.\\nData collection and analysis\\nFour reviewers independently assessed trial quality and eligibility for inclusion.\\nMain results\\nTwo trials (255 preterm infants, 23 0/7 to 32 6/7 weeks of gestation) were included in the analysis. UCM was associated with fewer intraventricular hemorrhages (IVHs) (two trials, 255 infants; relative risk [RR] 0.45, 95% confidence interval [CI] 0.20 to 0.98, low quality of evidence) and UCM was an increased proportion of infants with a Bayley score at 2 years of age (two trials, 174 infants; Cognitive: RR 1.14, 95% CI 1.03 to 1.26, Language: RR 1.24, 95% CI 1.03 to 1.49, low quality of evidence) compared to DCC.\\nConclusions\\nUCM wasn't reduced in-hospital mortality and need for transfusion compared to DCC. But our study suggests that UCM may lower the risk of IVH and improve certain neurodevelopmental outcomes compared to DCC in preterm infants.

Oligosaccharides help promote plant growth and resilience. In this study, chitosan oligosaccharide (CSOS), cello-oligosaccharide (COS), xylooligosaccharide (XOS), and oligomix (MixOS) (a mix of the three oligosaccharides (mass ratio 1:1:1)) were used to explore their possible regulatory abilities and mechanisms on tomatoes in normal conditions and chilling stress. In normal growth, the XOS had the greatest effect on increasing biomass (increased by 69.5%) in roots, and there was a significant increase (26.5%) of auxin (IAA) absorption. The COS increased main root length by 29.4%, but the content of methyl jasmonate (JA-ME) was 17% lower than other treatments. The MixOS was 2.7 times more effective in enhancing shoot biomass, and increased accumulation of IAA content by 30% above-ground. Under chilling stress, the plant photosynthetic activities and metabolic functions were less damaged with oligosaccharide treatments. In comparison to the control, COS, XOS, and CSOS effectively increased the content of soluble sugar and decreased the permeability of cell membrane, especially in the CSOS treatment in which soluble sugar increased by 37.8% and the permeability of cell membrane decreased by 35.4%. Similarly, the MixOS also possessed an effective resistance to chilling. These results suggested different oligosaccharides played different roles in plant growth, phenotype and resistance. The oligomix was the most effective in improving the plant growth and chilling tolerance. These novel results provide fundamental evidences for the development and application of oligosaccharide in sustainable agriculture.

Oxygen-containing carbon materials such as graphene oxide have been studied intensively for a decade because of the high oxygen content, which is beneficial to disperse carbon materials in solutions and to support either metals or metal oxides on carbon materials. However, various oxygen-containing functional groups exist on carbon materials and controlling the structures is almost impossible. In this work, phloroglucinol (PG), which has a symmetrical structure with three hydroxyl groups relative to six aromatic carbon atoms, was found to be the best precursor among PG, cyanuric acid, trimesic acid, and melamine because of the high yield (63 wt%) at 573 K even in an open system which is essential for mass production. The materials synthesized from PG also showed the high dispersibility and/or solubility in solvents (N-methyl-2-pyrrolidone and N,N-dimethylformamide) and the low temperature to form carbon materials (573 K), which can be explained from (002) and (10) in X-ray diffraction pattern. X-ray photoelectron spectroscopy, Fourier transform infrared spectrometer, carbon-13 nuclear magnetic resonance with the aid of calculation of both spectra and carbonization mechanisms revealed that the high solubility of carbonized PG originates from the presence of ether and cyclic ether, which were formed from dehydration of hydroxy groups, and also some remained hydroxyl groups in carbonized PG. Oxygen-containing groups in carbonized PG were effective as an antioxidant. In addition, the coating of carbonized PG on silica nanoparticles imparted conductivity and lubricity to silica nanoparticles.Graphic abstract

Reverse transcription-quantitative PCR (RT-qPCR)-based tests are widely used to diagnose coronavirus disease 2019 (COVID-19). As a result that these tests cannot be done in local clinics where RT-qPCR testing capability is lacking, rapid antigen tests (RATs) for COVID-19 based on lateral flow immunoassays are used for rapid diagnosis. However, their sensitivity compared with each other and with RT-qPCR and infectious virus isolation has not been examined. Here, we compared the sensitivity among four RATs by using severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) isolates and several types of COVID-19 patient specimens and compared their sensitivity with that of RT-qPCR and infectious virus isolation. Although the RATs read the samples containing large amounts of virus as positive, even the most sensitive RAT read the samples containing small amounts of virus as negative. Moreover, all RATs tested failed to detect viral antigens in several specimens from which the virus was isolated. The current RATs will likely miss some COVID-19 patients who are shedding infectious SARS-CoV-2.

Intermittent preventive treatment in pregnancy (IPTp) with sulfadoxine-pyrimethamine (SP) is a chemoprevention strategy against malaria in pregnancy. A recent PLOS Medicine study highlights the need for better understanding of the mechanism by which IPTp-SP reduces low birthweight, as well as novel measures to prevent malaria earlier in gestation.

Human microbiotas are communities of microorganisms living in symbiosis with humans. They play an important role in the host immune response to respiratory viral infection. However, evidence on the human microbiome and coronavirus disease (COVID-19) relationship is insufficient. The aim of this systematic literature review was to evaluate existing evidence on the association between the microbiome and COVID-19 in humans and summarize these data in the pandemic era. We conducted a systematic literature review on the association between the microbiome and COVID-19 in humans by searching PubMed, Embase, and the Cochrane Library, CINAHL, and Web of Science databases for articles in English published up to October 31, 2020. The results were analyzed qualitatively. This study is registered with PROSPERO (CRD42020195982). Of the 543 articles identified by searching databases, 16 in line with the research objectives were eligible for qualitative review: eight sampled the microbiome using stool, four using nasopharyngeal or throat swab, three using bronchoalveolar lavage fluid, and one using lung tissue. Fecal microbiome dysbiosis and increased opportunistic pathogens were reported in COVID-19 patients. Several studies suggested the dysbiosis in the lung microbiome of COVID-19 patients with an abundance of opportunistic pathogens using lower respiratory tract samples. The association between COVID-19 severity and the human microbiome remains uncertain. The human fecal and respiratory tract microbiome changed in COVID-19 patients with opportunistic pathogen abundance. Further research to elucidate the effect of alternation of the human microbiome in disease pathogenesis is warranted.

Investigators assessed the in vitro activities of seven monoclonal antibodies and three antiviral drugs against Covid-19 variants of concern. All the antibodies showed either no or weak neutralizing activity against the omicron variant; two agents that target the RNA polymerase and a protease inhibitor were effective at omicron neutralization.